Syngene International (BOM:539268) 5-Year EBITDA Growth Rate : 11.00% (As of Mar. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Syngene International 5-Year EBITDA Growth Rate?

Syngene International's EBITDA per Share for the three months ended in Mar. 2024 was ₹8.30.

During the past 12 months, Syngene International's average EBITDA Per Share Growth Rate was 9.20% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 12.20% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 11.00% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 15.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Syngene International was 32.50% per year. The lowest was 8.80% per year. And the median was 19.70% per year.

Competitive Comparison of Syngene International's 5-Year EBITDA Growth Rate

For the Biotechnology subindustry, Syngene International's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Syngene International's 5-Year EBITDA Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Syngene International's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Syngene International's 5-Year EBITDA Growth Rate falls into.

Syngene International 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Syngene International (BOM:539268) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.

Syngene International 5-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Syngene International's 5-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Syngene International (BOM:539268) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Syngene International Ltd (BOM:539268) » Definitions » 5-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

SYNGENE:India

Address

Jigani Link Road, Biocon SEZ, Biocon Park, Plot No. 2 and 3, IV Phase, Bommasandra Industrial Area, Bangalore, KA, IND, 560 099

Website

https://www.syngeneintl.com

Syngene International Ltd is a contract research and manufacturing organization in India. It supports research and development programs, from lead generation to clinical and commercial supplies. The company operates in India, the United States of America and other countries, of which a majority of the revenue is derived from the US. The company receives revenue by providing contract research and manufacturing services. It offers services such as Oligonucleotide synthesis, Bioinformatics, Clinical development services, polymer research, chemical development, safety assessment, discovery chemistry, discovery biology, and others.

Syngene International (BOM:539268) Headlines

No Headlines